Restoring activity‐dependent synaptic and microglial transcriptomic alterations in late‐stage Alzheimer’s Disease
Amira Latif‐Hernandez, Robert R Butler III, Patricia Moran‐Losada, Tao Yang, Kevin C Tran, Harry Liu, Tony Wyss‐Coray, Frank M Longo · 2025
Read Restoring activity‐dependent synaptic and microglial transcriptomic alterations in late‐stage Alzheimer’s Disease by Amira Latif‐Hernandez, Robert R Butler III, Patricia Moran‐Losada, Tao Yang, Kevin C Tran, Harry Liu, Tony Wyss‐Coray, Frank M Longo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713842.txt.
Description
Amira Latif-Hernandez and co-authors test a drug that aims to restore gene activity in late-stage Alzheimer's in mice in a 2025 paper. Learning switches on sets of genes that lock in memory, and that switch fails in the disease. The drug boosts signals from two growth receptors on nerve cells. Earlier work showed it spares synapses, the links between cells.
Aged Alzheimer's model mice got the drug by mouth daily for three months. Slices of the memory center were then jolted to mimic learning, and gene activity was read out. In untreated sick mice, the learning response failed. Treated mice responded much like healthy ones. The drug also shifted immune cell genes tied to the disease.
Catalog record
| CREATOR | Amira Latif‐Hernandez, Robert R Butler III, Patricia Moran‐Losada, Tao Yang, Kevin C Tran, Harry Liu, Tony Wyss‐Coray, Frank M Longo |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |